Company / Current Assets
Dyne Therapeutics, Inc. Current Assets History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$659.3M
FY2024
5-year range
$129.4M / $659.3M
FY2020-FY2024
Trend
+409.6%
vs FY2023
Sector context
#92 of 215
Health Care
What the data says
Current Assets changed +410% YoY in FY2024, a notable deviation from the 5-year average annual change of +521%.
Based on SEC 10-K filings.
$659M in FY2024 with a 5-year CAGR of +113.8%.
Improved from $266M to $659M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +19.9%
- 5-Year CAGR
- +113.8%
- 10-Year CAGR
- -
Sector benchmark
#92 of 215 in Health CareTop 43% of 215This company $659.3M Sector average $2.5B
▼
-74.0% below sector average
Key checks
Key Insights
- 5-year CAGR of +113.8%, indicating consistent growth.
- In FY2024, current assets increased 409.6% year-over-year.
- Ranks #92 out of 215 companies in the Health Care sector.
- Lowest current assets in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 3.40 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $659.3M | +409.6% |
| FY2023 | $129.4M | -51.3% |
| FY2022 | $265.6M | -30.5% |
| FY2021 | $382.4M | +9.5% |
| FY2020 | $349.1M | +2265.2% |
| FY2019 | $14.8M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026